Back to: Facilitating Generic Drug Product Development through Product-Specific Guidances
🔔 Note: Stop playback at 1:12:43 to complete this lesson.
Presenter
Karthika Natarajan, PhD
Staff Fellow
Division of Therapeutic Performance I (DTP I)
Office of Research and Standards (ORS)
Office of Generic Drugs (OGD)
Center for Drug Evaluation and Research (CDER)
US Food and Drug Administration (FDA)